Francisco Silva is VP of Research and Development of BioRestorative Therapies, Inc.. Currently has a direct ownership of 155,759 shares of BRTX, which is worth approximately $239,868. The most recent transaction as insider was on Apr 09, 2024, when has been sold 6,600 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $8,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 156K
0% 3M change
5.4% 12M change
Total Value Held $239,868

Francisco Silva Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 09 2024
BUY
Open market or private purchase
$8,250 $1.25 p/Share
6,600 Added 4.07%
155,759 Common Stock
Apr 08 2024
BUY
Open market or private purchase
$1,964 $1.15 p/Share
1,708 Added 1.13%
149,159 Common Stock
Mar 18 2024
SELL
Payment of exercise price or tax liability
$23,898 $1.39 p/Share
17,193 Reduced 10.44%
147,451 Common Stock
Aug 31 2023
BUY
Open market or private purchase
$10,997 $2.22 p/Share
4,954 Added 2.92%
164,644 Common Stock
Mar 31 2023
BUY
Open market or private purchase
$2,659 $3.56 p/Share
747 Added 0.47%
159,690 Common Stock
Mar 20 2023
SELL
Payment of exercise price or tax liability
$19,648 $2.92 p/Share
6,729 Reduced 4.06%
158,943 Common Stock
Feb 18 2023
SELL
Payment of exercise price or tax liability
$1,118 $2.99 p/Share
374 Reduced 0.23%
165,672 Common Stock
Nov 21 2022
BUY
Open market or private purchase
$2,470 $2.62 p/Share
943 Added 0.56%
166,046 Common Stock
Oct 12 2022
BUY
Open market or private purchase
$2,458 $3.39 p/Share
725 Added 0.44%
165,103 Common Stock
Oct 11 2022
BUY
Open market or private purchase
$2,974 $3.69 p/Share
806 Added 0.49%
164,378 Common Stock
Aug 29 2022
BUY
Open market or private purchase
$9,039 $3.21 p/Share
2,816 Added 1.69%
163,572 Common Stock
Aug 26 2022
SELL
Open market or private sale
$13,418 $3.39 p/Share
3,958 Reduced 2.44%
158,156 Common Stock
Aug 26 2022
BUY
Open market or private purchase
$8,710 $3.35 p/Share
2,600 Added 1.59%
160,756 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
$994 $3.78 p/Share
263 Added 0.16%
162,114 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
$2,627 $4.65 p/Share
565 Added 0.35%
161,851 Common Stock
Mar 18 2022
BUY
Grant, award, or other acquisition
-
12,438 Added 7.16%
161,286 Common Stock
Mar 18 2021
BUY
Grant, award, or other acquisition
-
586,958,987 Added 49.64%
595,390,616 Common Stock
Nov 23 2020
BUY
Other acquisition or disposition
-
8,375,671 Added 49.83%
8,431,629 Common Stock
FS

Francisco Silva

VP of Research and Development
Melville, NY

Track Institutional and Insider Activities on BRTX

Follow BioRestorative Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BRTX shares.

Notify only if

Insider Trading

Get notified when an Bio Restorative Therapies, Inc. insider buys or sells BRTX shares.

Notify only if

News

Receive news related to BioRestorative Therapies, Inc.

Track Activities on BRTX